Dynavax appoints chief medical officer
This article was originally published in Scrip
Dynavax Technologies (US) has named Dr Tyler Martin chief medical officer. He will manage the company's clinical affairs, including the development of three current clinical-stage product candidates and three preclinical candidates, which are expected to enter development within the next year. Dr Martin has almost 20 years' experience in the biotechnology industry, having most recently served as president of Humabs, and before that as vice-president of development at Chiron.